PRICE-F(X)
Price f(x), a leader in Price Optimization & Management SaaS, has been named a “Cool Vendor in Digital Commerce” in the 2018 report by Gartner® , Inc.1
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005662/en/
Price f(x) is the pioneer of native Price Optimization & Management SaaS (“PO&M SaaS”) offering uniquely flexible, functionally broad and fast to implement solutions. In the report, Gartner® highlights Price f(x) as a true disruptor in this software segment through uncompromised customer-centric approach best reflected in the commercial offering of Pricing-as-a-Service (“PraaS™”). “We are devoted to simplicity, relevance and agility, but most importantly to commercial fairness. Our solution is designed, both technically and commercially, to quickly provide value to companies of any size, in any industry, in B2B, B2C as well as B2B2C. And offering all of that entirely free of implementation costs in our PraaS™ offering – truly is cool,” said Marcin Cichon, CEO of Price f(x).
According to Gartner® , “(…) the PraaS™ model, combined with contract terms as short as three months, shifts much of the project risk to the vendor and requires no capital expenditure by the customer. The total cost of a Price f(x) project can be less than one-quarter of that of its more established competitors . Gartner® clients report that this zero-capital-expenditure, low-risk offering is compelling, and have been pleased with project outcomes.”1 .
“We are very happy that our unique commercial approach, focusing on the total elimination of customer risks related to adoption of our technology, and its full market impact has been recognized by Gartner® ,” said Billy Graham, VP Ecosystem at Price f(x).
Since its market entry in late 2012, Price f(x) has been the fastest growing software company in the PO&M SaaS market. In 2017, Price f(x) introduced the “PFX Platform” and its front-end integration to the world’s leading CRM applications – Salesforce® , SAP Hybris C4C® and Microsoft Dynamics® . The decision to not just offer limited functionality Pricing Apps on top of those CRM solutions but to seamlessly mashup into them with powerful price optimization, promotion and rebate management as well as transactional pricing functionality, marks a new dimension in the Digital Commerce.
“Being named a Gartner® Cool Vendor means for us an undeniable market validation of our attractive commercial approach,” said Patrick Adams, SVP Commercial Excellence at Price f(x). “Our unprecedented model truly works both ways, providing our customers with unmatched value and acceleration in market adoption, while allowing us to scale up quickly to achieve profitable growth.”
One of Price f(x)’s many marquee customers Sonoco and valued partner Big Data Pricing will host together an online webinar How Change Management Drives Price Transformation Success on June 5th to demonstrate how “cool” technology can help in solution adoption and resulting change management success when implementing complex pricing solutions. We encourage everyone to register at https://go.pricefx.eu/sonoco-bdp-2018-webinar and get inspired by this true success story.
Gartner subscribers and clients can access the report here Gartner Cool Vendors in Digital Commerce .
1 Gartner, Inc., “Cool Vendors in Digital Commerce” by Mark Lewis, et al, on May 16, 2018.
Required Disclaimer
Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner® research publications consist of the opinions of Gartner® 's research organization and should not be construed as statements of fact. Gartner® disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Price f(x)
Founded in 2011 in Germany, Price f(x) AG provides a full suite price optimization, management and CPQ SaaS solution based on a native cloud architecture, offering broad and flexible support across the entire price management lifecycle, including Price Strategy, Controlling, Setting, Optimization, and Realization. The solution is suitable for B2B and B2C as well as any industry facing the classical but also particular pricing challenges of commercial organizations of any size and geographical location. Price f(x)’s vision is to remain the leading SaaS pricing and CPQ solution provider through offering easy to use, fast to implement, flexible to adapt, risk-free and inexpensive, comprehensive solutions. Price f(x)’s business model is entirely based on satisfaction and loyalty of their customers versus enforcing long-term commitments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180522005662/en/
Contact:
Price f(x)
Media and Investor Relations
Billy Graham,
VP Ecosystem
+420 226 254 980
billy.graham@pricefx.eu
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom